{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:05:11Z","timestamp":1790949911219,"version":"4.1.0"},"reference-count":35,"publisher":"China Science Publishing & Media Ltd.","issue":"2","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2013,2,1]]},"DOI":"10.1093\/abbs\/gms100","type":"journal-article","created":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T04:30:47Z","timestamp":1353645047000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":22,"title":["Antioxidant effect of apolipoprotein A-I on high-fat diet-induced non-alcoholic fatty liver disease in rabbits"],"prefix":"10.3724","volume":"45","author":[{"given":"Weina","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2013,2,1]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.dld.2010.01.016","volume":"42","author":"Vanni E","year":"2010","unstructured":"Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-J\u00e4rvinen H, Svegliati-Baroni G. From the metabolic syndrome to NAFLD or vice versa?. Dig Liver Dis, 2010, 42: 320-330.","journal-title":"Dig Liver Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/ajcn\/86.2.285","volume":"86","author":"Zivkovic AM","year":"2007","unstructured":"Zivkovic AM, German JB, Sanyal A. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr, 2007, 86: 285-300.","journal-title":"Am J Clin Nutr"},{"key":"null","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmed.2007.12.003","volume":"14","author":"Marra F","year":"2008","unstructured":"Marra F, Gastaldelli A, Svegliati-Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med, 2008, 14: 72-81.","journal-title":"Trends Mol Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbalip.2009.10.007","volume":"180","author":"Trauner M","year":"2010","unstructured":"Trauner M, Arrease M, Wangner M. Fatty liver and lipotoxicity. Biochim Biophys Acta, 2010, 180: 299-310.","journal-title":"Biochim Biophys Acta"},{"key":"null","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.21347","volume":"44","author":"Williams R","year":"2006","unstructured":"Williams R. Global challenges in liver disease. Hepatology, 2006, 44: 521-526.","journal-title":"Hepatology"},{"key":"null","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1464-5491.2007.02025.x","volume":"24","author":"Targher G","year":"2007","unstructured":"Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med, 2007, 24: 1-6.","journal-title":"Diabet Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10620-009-1081-0","volume":"55","author":"Lewis JR","year":"2010","unstructured":"Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci, 2010, 55: 560-578.","journal-title":"Dig Dis Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cca.2011.04.013","volume":"412","author":"Koek GH","year":"2011","unstructured":"Koek GH, Liedorp PR, Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta, 2011, 412: 1297-1305.","journal-title":"Clin Chim Acta"},{"key":"null","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.lfs.2009.02.026","volume":"84","author":"Roberts CK","year":"2009","unstructured":"Roberts CK, Sindhu K. Oxidative stress and metabolic syndrome. Life Sci, 2009, 84: 705-712.","journal-title":"Life Sci"},{"key":"null","first-page":"57","volume":"34","author":"Koruk M","year":"2004","unstructured":"Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci, 2004, 34: 57-62.","journal-title":"Ann Clin Lab Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4155\/cli.10.24","volume":"1","author":"Lam B","year":"2011","unstructured":"Lam B, Younossi Z. Novel treatment strategies for patients with nonalcoholic fatty liver disease. Clin Invest, 2011, 1: 229-239.","journal-title":"Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/jn\/138.10.1872","volume":"138","author":"Baumgardner JN","year":"2008","unstructured":"Baumgardner JN, Shankar K, Hennings L, Albano E, Badger TM, Ronis MJJ. N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis. J Nutr, 2008, 138: 1872-1879.","journal-title":"J Nutr"},{"key":"null","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbt.20109","volume":"20","author":"Oz HS","year":"2006","unstructured":"Oz HS, Im HJ, Chen TS, de Villiers WJS, McClain CJ. Glutathioneenhancing gents protect against steatohepatitis in dietary model. J Biochem Mol Toxicol, 2006, 20: 39-47.","journal-title":"J Biochem Mol Toxicol"},{"key":"null","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/hep.22029","volume":"47","author":"Li J","year":"2008","unstructured":"Li J, Bardag-Gorce F, Dedes J, French BA, Amidi F, Oliva J, French SW. Sadenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory. Hepatology, 2008, 47: 613-624.","journal-title":"Hepatology"},{"key":"null","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.trsl.2011.12.003","volume":"159","author":"Salamone F","year":"2012","unstructured":"Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Volti GL. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Transl Res, 2012, 159: 477-486.","journal-title":"Transl Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.freeradbiomed.2012.02.008","volume":"52","author":"Loguercio C","year":"2012","unstructured":"Loguercio C, Andreone P, Brisc C, Brisc MC, Bugianesi E, Chiaramonte M, Cursaro C. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial. Free Radic Biol Med, 2012, 52: 1658-1665.","journal-title":"Free Radic Biol Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2009.05.034","volume":"208","author":"Tsompanidi EM","year":"2010","unstructured":"Tsompanidi EM, Brinkmeier MS, Fotiadou EH, Giakoumi SM, Kypreos KE. HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis. Atherosclerosis, 2010, 208: 3-9.","journal-title":"Atherosclerosis"},{"key":"null","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MOL.0b013e3282364a17","volume":"18","author":"Ansell BJ","year":"2007","unstructured":"Ansell BJ, Fonarow GC, Fogelman AM. The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipidol, 2007, 18: 427-434.","journal-title":"Curr Opin Lipidol"},{"key":"null","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/1071576021000036614","volume":"37","author":"Jaouad L","year":"2003","unstructured":"Jaouad L, Milochevitch C, Khalil A. PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity. Free Radic Res, 2003, 37: 77-83.","journal-title":"Free Radic Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0300-8932(10)70091-9","volume":"63","author":"Badimon JJ","year":"2010","unstructured":"Badimon JJ, Ibanez B. Increasing high-density lipoprotein as a therapeutic target in atherothrombotic disease. Rev Esp Cardiol, 2010, 63: 323-333.","journal-title":"Rev Esp Cardiol"},{"key":"null","first-page":"258","volume":"3","author":"Camont L","year":"2011","unstructured":"Camont L, Chapman J, Kontush A. Functionality of HDL particles: heterogeneity and relationships to cardiovascular disease. Arch Cardiovasc Dis, 2011, 3: 258-266.","journal-title":"Arch Cardiovasc Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0022-2275(20)33462-3","volume":"41","author":"Navab M","year":"2000","unstructured":"Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res, 2000, 41: 1495-1508.","journal-title":"J Lipid Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"742","DOI":"10.7326\/0003-4819-155-11-201112060-00006","volume":"155","author":"Mora S","year":"2011","unstructured":"Mora S, Buring JE, Ridker PM, Cui YD. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study. Ann Intern Med, 2011, 155: 742-750.","journal-title":"Ann Intern Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0022-2275(20)33461-1","volume":"41","author":"Navab M","year":"2000","unstructured":"Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, Subbanagounder G. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res, 2000, 41: 1481-1494.","journal-title":"J Lipid Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jinorgbio.2008.11.017","volume":"103","author":"Lanza V","year":"2009","unstructured":"Lanza V, Vecchio G. New conjugates of superoxide dismutase\/catalase mimetics with cyclodestrins. J Inorg Biochem, 2009, 103: 381-388.","journal-title":"J Inorg Biochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.clinbiochem.2007.02.006","volume":"40","author":"Baskol G","year":"2007","unstructured":"Baskol G, Baskol M, Kocer D. Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis. Clin Biochem, 2007, 40: 776-780.","journal-title":"Clin Biochem"},{"key":"null","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1478-3231.2005.01126.x","volume":"25","author":"Perlemuter G","year":"2005","unstructured":"Perlemuter G, Davit-Spraul A, Cosson C, Conti M, Bigorgne A, Paradis V, Corre MP. Increase in liver antioxidant enzyme activities in nonalcoholic fatty liver disease. Liver Int, 2005, 25: 946-953.","journal-title":"Liver Int"},{"key":"null","first-page":"4330","volume":"7","author":"Shing HG","year":"2003","unstructured":"Shing HG, Zhao J, Yao DF, Wu XH, Qiu LW, Wu W. Expression and dynamic alteration of inducible nitric oxide synthase messenger RNA after spinal cord injury in rats [in Chinese]. J Clin Rehabil, 2003, 7: 4330-4331.","journal-title":"J Clin Rehabil"},{"key":"null","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pathophys.2006.05.002","volume":"13","author":"Singh U","year":"2006","unstructured":"Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology, 2006, 13: 129-142.","journal-title":"Pathophysiology"},{"key":"null","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"Brunt EM","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol, 1999, 94: 2467-2474.","journal-title":"Am J Gastroenterol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/hep.20177","volume":"39","author":"Laurent A","year":"2004","unstructured":"Laurent A, Nicco C, Van Nhieu JT, Borderie D, Chereau C, Conti F, Jaffray P. Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology, 2004, 39: 1277-1285.","journal-title":"Hepatology"},{"key":"null","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1074\/jbc.273.11.6080","volume":"273","author":"Garner B","year":"1998","unstructured":"Garner B, Witting PK, Waldeck AR, Christison JK, Raftery M, Stocker R. Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol. J Biol Chem, 1998, 273: 6080-6087.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","volume":"18","author":"Takahashi Y","year":"2012","unstructured":"Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J Gastroenterol, 2012, 18: 2300-2308.","journal-title":"World J Gastroenterol"},{"key":"null","first-page":"441","volume":"26","author":"Pettinelli P","year":"2011","unstructured":"Pettinelli P, Obregon AM, Videla LA. Molecular mechanisms of steatosis in nonalcoholic fatty liver disease. Nutr Hosp, 2011, 26: 441-450.","journal-title":"Nutr Hosp"},{"key":"null","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","volume":"52","author":"Rolo AP","year":"2012","unstructured":"Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radical Biol Med, 2012, 52: 59-69.","journal-title":"Free Radical Biol Med"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/F5740D08BF2144A9901693F9B130CE36","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gms100","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/F5740D08BF2144A9901693F9B130CE36","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:24:03Z","timestamp":1687825443000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gms100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,1]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,1]]},"published-print":{"date-parts":[[2013,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gms100","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,1]]}}}